Qian Chu

23PUBLICATIONS
113CO-AUTHORS
Cancer cell biologyMolecular targetsCancer diagnosisHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 19, 2026
Glycolytic reprogramming in cancer: tumour cell metabolism, immune modulation, and therapeutic opportunities.

|Jun 17, 2026
Intermediate accumulated upon interruption of fatty acid oxidation flux promotes tumoral ferroptosis and improves immunotherapy.

|May 19, 2026
PancDS in Real-World Practice: A Prospective Multicenter Validation of a Clinical Decision-Support System Bridging Experience Gaps in Pancreatic Lesion Diagnosis.

|Apr 21, 2026
TMEM87A suppresses ferroptosis and increases cancer immunotherapy resistance by maintaining the Golgi apparatus pH homeostasis.

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Feb 09, 2026
Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response.

Ming Yi, Tianye Li, Yinhui Gu

Pageof 4

Frequent Collaborators

3 joint publications

Xindong Liu

3 joint publications

Weimin Wang

3 joint publications

Lin Wu

3 joint publications

Bo Zhu